Top Midday Stories: Boeing Wins Multibillion Dollar Contract to Build Fighter Jet; FedEx Shares Fall on Earnings Miss, Downbeat Guidance

MT Newswires Live
18 hours ago

All three major US stock indexes were down in midday trading as markets appear as though they will end the week on a gloomy note.

In company news, Boeing (BA) has won a multibillion-dollar contract to design and build a fighter jet for the US Air Force, beating Lockheed Martin (LMT), according to media reports Friday. Boeing shares were up 5.3% at noon. Lockheed shares were down roughly 6%.

FedEx (FDX) reported fiscal Q3 adjusted earnings late Thursday of $4.51 per diluted share, up from $3.86 a year earlier but below the consensus estimate of analysts polled by FactSet calling for $4.56. Fiscal Q3 revenue was $22.2 billion, up from $21.7 billion in the year-ago period and above the FactSet consensus of $21.87 billion. The company said it now expects fiscal 2025 adjusted EPS of between $18 and $18.60, down from the previous guidance of $19 to $20. Analysts expect $18.93. FedEx also expects flat to slightly lower revenue for the fiscal year compared to previous guidance of about flat revenue. FedEx shares were down 8.8%.

AstraZeneca (AZN) will invest $2.5 billion in a new research facility in Beijing just months after the company's top executive there was detained by Chinese authorities, Bloomberg reported Friday. AstraZeneca shares were down 1.6%.

Nike (NKE) reported fiscal Q3 earnings late Thursday of $0.54 per diluted share, down from $0.77 in the year-ago period but above the FactSet consensus of $0.28. Fiscal Q3 revenue was $11.27 billion, down from $12.43 billion a year earlier but above the FactSet consensus of $11.02 billion. The company expects revenue to be down at the low end of a mid-teens range in the ongoing quarter, reflecting unfavorable shipment timing in North America and foreign exchange headwinds, Chief Financial Officer Matthew Friend said on a call with analysts. Nike shares were down 5.6%.

Elliott Management, which holds nearly a 5% stake in BP (BP), has urged the energy company to make more aggressive changes, including cost-cutting measures and a possible reshuffling of its leadership, Reuters reported Friday, citing two major shareholders. Elliott is pushing for a reduction in BP's annual spending to below $13 billion and urging for a sale of a significant portion of the company's petrol station network, Reuters reported, citing a source familiar with the matter. Separately, BP and Apollo Global Management (APO) said Friday they reached an agreement for Apollo-managed funds to buy a 25% non-controlling stake in BP's 12% interest in the pipeline carrying natural gas from Azerbaijan through Turkey. Apollo will pay about $1 billion for a stake in BP TANAP, the subsidiary that holds BP's interest in the 1,800-kilometer pipeline, the companies said. BP shares were down 0.7%, while those of Apollo were down 1.1%.

Johnson & Johnson (JNJ) said Friday it plans to increase its US investment to more than $55 billion over the next four years to boost its manufacturing and research capabilities. The investment represents a 25% increase to the previous four years, Johnson & Johnson said. Shares of the company were up 0.3%.

Price: 180.05, Change: +7.22, Percent Change: +4.18

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10